• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病的流行病学及全球影响

Epidemiology and global impact of chronic obstructive pulmonary disease.

作者信息

Mannino David M

机构信息

Division of Pulmonary and Critical Care Medicine, University of Kentucky School of Medicine, 800 Rose Street, Lexington, KY 40536, USA.

出版信息

Semin Respir Crit Care Med. 2005 Apr;26(2):204-10. doi: 10.1055/s-2005-869539.

DOI:10.1055/s-2005-869539
PMID:16088437
Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that causes a heavy health and increasing economic burden both in the United States and around the world. Most of the risk factors for COPD are well known and include smoking, occupational exposures, air pollution, airway hyperresponsiveness, asthma, and certain genetic variations, although many questions, such as why a minority of smokers develop significant airway obstruction, remain. Major medical organizations have agreed on a common definition of COPD, although newer measures, such as functional status or exercise capability, have emerged as important in determining the prognosis of COPD patients. In most of the world, COPD prevalence and mortality are still increasing and will likely continue to rise in response to increases in smoking, particularly by women and adolescents. Resources aimed at smoking cessation and prevention, COPD education and early detection, and better treatment will be of the most benefit in our continuing efforts against this important cause of morbidity and mortality.

摘要

慢性阻塞性肺疾病(COPD)是一种可预防和可治疗的疾病,在美国乃至全球都造成了沉重的健康负担,并使经济负担不断加重。COPD的大多数风险因素已为人熟知,包括吸烟、职业暴露、空气污染、气道高反应性、哮喘以及某些基因变异,不过仍存在诸多问题,比如为何少数吸烟者会出现严重的气道阻塞。尽管诸如功能状态或运动能力等新指标在判定COPD患者的预后方面已变得至关重要,但各大主要医学组织已就COPD的通用定义达成共识。在世界上大多数地区,COPD的患病率和死亡率仍在上升,并且随着吸烟人数的增加,尤其是女性和青少年吸烟人数的增加,很可能会继续攀升。旨在戒烟与预防、COPD教育与早期检测以及更好治疗的资源,将对我们持续抗击这一导致发病和死亡的重要病因发挥最大益处。

相似文献

1
Epidemiology and global impact of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的流行病学及全球影响
Semin Respir Crit Care Med. 2005 Apr;26(2):204-10. doi: 10.1055/s-2005-869539.
2
Chronic obstructive pulmonary disease: definition and epidemiology.慢性阻塞性肺疾病:定义与流行病学
Respir Care. 2003 Dec;48(12):1185-91; discussion 1191-3.
3
The epidemiology and economics of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的流行病学与经济学
Proc Am Thorac Soc. 2007 Oct 1;4(7):502-6. doi: 10.1513/pats.200701-001FM.
4
COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity.慢性阻塞性肺疾病:流行病学、患病率、发病率和死亡率以及疾病异质性。
Chest. 2002 May;121(5 Suppl):121S-126S. doi: 10.1378/chest.121.5_suppl.121s.
5
COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.慢性阻塞性肺疾病作为一种具有全身影响的肺部疾病——临床影响、机制及早期干预潜力
COPD. 2008 Aug;5(4):235-56. doi: 10.1080/15412550802237531.
6
A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure.一项关于慢性阻塞性肺疾病流行病学及其与吸烟和环境烟草烟雾暴露关系的多中心研究。
Indian J Chest Dis Allied Sci. 2006 Jan-Mar;48(1):23-9.
7
Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.慢性阻塞性肺疾病的直接医疗费用:慢性支气管炎和肺气肿
Respir Med. 2000 Mar;94(3):204-13. doi: 10.1053/rmed.1999.0720.
8
Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.全球烟草控制视角。第一部分。烟草流行的全球状况。
Int J Tuberc Lung Dis. 2008 Jan;12(1):3-7.
9
[The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].[德国慢性阻塞性肺疾病(COPD)的患病率。BOLD研究结果]
Dtsch Med Wochenschr. 2008 Dec;133(50):2609-14. doi: 10.1055/s-0028-1105858. Epub 2008 Dec 3.
10
Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries.高收入和低收入国家的室外及室内空气污染与慢性阻塞性肺疾病相关疾病
Int J Tuberc Lung Dis. 2008 Feb;12(2):115-27.

引用本文的文献

1
Role of toll-like receptors and nod-like receptors in acute lung infection. toll 样受体和核苷酸结合寡聚化结构域样受体在急性肺感染中的作用。
Front Immunol. 2023 Aug 16;14:1249098. doi: 10.3389/fimmu.2023.1249098. eCollection 2023.
2
Traffic Density-Related Black Carbon Distribution: Impact of Wind in a Basin Town.交通密度相关黑碳分布:盆地城镇风的影响。
Int J Environ Res Public Health. 2021 Jun 16;18(12):6490. doi: 10.3390/ijerph18126490.
3
Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study.
法国 COPD 住院患者的双联与三联治疗:一项基于索赔数据的研究。
Int J Chron Obstruct Pulmon Dis. 2019 Aug 20;14:1839-1854. doi: 10.2147/COPD.S214061. eCollection 2019.
4
Effect of physical therapy for chronic obstructive pulmonary disease: A protocol for an updated systematic review of randomized controlled trial.物理治疗对慢性阻塞性肺疾病的影响:一项更新的随机对照试验系统评价方案
Medicine (Baltimore). 2019 Sep;98(38):e17241. doi: 10.1097/MD.0000000000017241.
5
Improvement in hypercapnia does not predict survival in COPD patients on chronic noninvasive ventilation.高碳酸血症的改善并不能预测慢性无创通气的慢性阻塞性肺疾病(COPD)患者的生存率。
Int J Chron Obstruct Pulmon Dis. 2018 Nov 1;13:3625-3634. doi: 10.2147/COPD.S169951. eCollection 2018.
6
Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".西班牙慢性阻塞性肺疾病(COPD)表型患病率及分布的地理差异:“ESPIRAL-ES研究”
Int J Chron Obstruct Pulmon Dis. 2018 Apr 10;13:1115-1124. doi: 10.2147/COPD.S158031. eCollection 2018.
7
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors.新型噻唑-2-(3H)-酮作为人中性粒细胞弹性蛋白酶(HNE)抑制剂的合成与分析表征
Chem Cent J. 2017 Dec 6;11(1):127. doi: 10.1186/s13065-017-0358-1.
8
Clinical and fiberoptic endoscopic assessment of swallowing in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者吞咽功能的临床及纤维内镜评估
Int Arch Otorhinolaryngol. 2013 Jul;17(3):274-8. doi: 10.7162/S1809-97772013000300007.
9
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.优化 N-苯甲酰基吲唑衍生物作为人中性粒细胞弹性蛋白酶抑制剂。
J Med Chem. 2013 Aug 8;56(15):6259-72. doi: 10.1021/jm400742j. Epub 2013 Jul 25.
10
COPD surveillance--United States, 1999-2011.慢性阻塞性肺疾病监测——美国,1999-2011 年。
Chest. 2013 Jul;144(1):284-305. doi: 10.1378/chest.13-0809.